Related Experiment Video
Updated: Apr 5, 2026
09:03
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
20.0K
Animal models for the study of HCV
Koen Vercauteren1, Ype P de Jong2, Philip Meuleman3
1Center for Vaccinology, Dept. of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, USA.
Current Opinion in Virology
|August 26, 2015
Summary
Developing suitable animal models is crucial for studying hepatitis C virus (HCV) infection and developing effective treatments. Current models aid in understanding the HCV life cycle and antiviral interventions.
Area of Science:
- Virology
- Immunology
- Hepatology
Background:
- Hepatitis C virus (HCV) research has been limited by the lack of appropriate small animal models.
- Existing immunocompromised mouse models support the complete HCV life cycle and antiviral studies.
- HCV infection can lead to severe liver conditions like fibrosis, cirrhosis, and hepatocellular carcinoma (HCC).
Purpose of the Study:
- To review available in vivo models for studying HCV.
- To highlight the need for immunocompetent models for comprehensive HCV research.
- To facilitate better understanding of HCV pathogenesis and treatment.
Main Methods:
- Literature review of existing in vivo models for HCV study.
- Analysis of model systems supporting the full HCV life cycle.
- Evaluation of models for studying HCV-associated histopathological manifestations.
Main Results:
- Immunocompromised mouse models are valuable for studying the HCV life cycle and antiviral therapies.
- These models have limitations in fully recapitulating HCV persistence and associated liver diseases.
- The development of permissive, immunocompetent models is essential for advancing HCV research.
Conclusions:
- Effective therapies and vaccines for HCV require robust animal models.
- Current models provide insights but do not fully replicate human HCV infection.
- Further development of small animal models is critical for understanding HCV pathogenesis and improving patient outcomes.
